Doubtlier, gaboratory, whenure, coffree. Start the new year off with words you didn’t know you needed. ScienceCareers
Experimental Error is a column about the quirky, comical, and sometimes bizarre world of scientific training and careers, written by scientist and comedian Adam Ruben.One of the most difficult impulses for scientists to curb is the tendency to use specialized language that no one else understands. Every scientific facility I’ve worked in has had its own specific vocabulary, and every scientist has had their own inscrutable, hyperspecific terms for aspects of their project.
But if you’ve ever sat through a seminar or hacked your way through a journal article, you’ve also been the victim of another scientist’s jargon. And that doesn’t feel so great, does it? Now you’re the one slogging through verbiage and perhaps questioning whether you belong among the ranks of the learned.
A grant application that you know you really ought to submit, but geez, it’s a lot of work and it probably won’t pay off and I’m busy and I’m going to go Google “industry jobs,” you know, just to lookA union, which is generally for employees, contractors, and others who exchange labor for pay—yet, for some reason, not for youThe debate that ensues in one’s mind when determining whether leaving the lab to quickly use the restroom during a period of data gathering will significantly impact one’s...
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Report shares new details about death possibly linked to experimental Alzheimer's drug | CNNThe death of a participant in a clinical trial of an antibody treatment for Alzheimer’s disease, which is now under consideration by the US Food and Drug Administration, may be linked to the experimental drug, a new report shows.
Read more »
FDA approves new experimental Alzheimer's drugThe Food and Drug Administration granted accelerated approval for Eisai and Biogen's experimental Alzheimer's drug, lecanemab, on Friday, offering a new treatment option for the more than 6.5 million people with Alzheimer's in the United States.
Read more »
New logo, new features, same great taste: Welcome to the new L.A. Times FoodFrom Times editors Laurie Ochoa and Daniel Hernandez: There's no better place or moment for eating and cooking than in Los Angeles right now.
Read more »
FDA grants fast-track approval to experimental Alzheimer's drugThe FDA approved lecanemab, which has shown to slow the progression of Alzheimer's disease.
Read more »
Tiny Space Force weather cubesat went up on SpaceX Falcon 9 rocketThe experimental EWS cubesat will operate in Earth orbit for a year.
Read more »
If You Have A 2023 New Year's Resolution, Now's Your Chance To Share What It Is With Everyone ElseNew year, new you.
Read more »